Library / regulatory-reference
Zimbabwe: Medicines Control Authority of Zimbabwe (MCAZ)
Audience: administrators-policy, researchers-scientists ยท Review state: published
The national authority
The Medicines Control Authority of Zimbabwe, known as the MCAZ, is Zimbabwe's national regulator for medicines and medical devices, established under the national medicines and allied substances control law.
Zimbabwe's supply combines imports with a domestic manufacturing sector, and the authority's registration, licensing and laboratory decisions govern the market.
How products enter the market
Medicines require registration after evaluation of quality, safety and efficacy, and manufacturers, importers, wholesalers and pharmacies are licensed and inspected.
The authority operates quality-control laboratory testing and runs pharmacovigilance and market-surveillance programs, with recall powers for defective products.
Regional and international role
The authority is one of the longer-established regulators in Southern Africa and participates in regional work-sharing, including the ZAZIBONA joint-assessment initiative.
Its regulatory maturity has made it a reference point for capacity building among neighboring authorities.
Using this profile
The authority publishes guidelines, registers and safety communications in English through its official portal, which is the primary source for current rules and listed in this profile's internal reference record.
For cross-country comparison: the MCAZ illustrates the long-standing anglophone-African regulator: an established authority with laboratory capacity anchoring its market supervision.
Limitations
Educational profile of a national regulatory system, current as of drafting. It simplifies routes and classes and is not legal, regulatory, or clinical advice. Filing and compliance decisions must be confirmed against the authority's current published rules and, where needed, professional regulatory counsel.